StockData
Pure Bioscience, Inc. logo

Pure Bioscience, Inc. (PURE) stock

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Pure Bioscience enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Pure Bioscience's enterprise value was $8.03M on Oct 19, 2026, against $7.50M a year earlier. Over the last 5 years it ranged from $4.27M to $26.39M, with a median of $9.51M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$8.03M+88.2%
2025Dec 31, 2025$4.27M-37.2%
2024Dec 31, 2024$6.79M-48.2%
2023Dec 29, 2023$13.10M+102.9%
2022Dec 30, 2022$6.46M-56.8%
2021Dec 31, 2021$14.94M-76.8%
2020Dec 31, 2020$64.45M+189.1%
2019Dec 31, 2019$22.29M-15.6%
2018Dec 31, 2018$26.43M-56.9%
2017Dec 29, 2017$61.28M+17.1%
2016Dec 30, 2016$52.33M+11.5%
2015Dec 31, 2015$46.95M+190.6%
2014Dec 31, 2014$16.15M-38.8%
2013Dec 31, 2013$26.38M+504.8%
2012Dec 31, 2012$4.36M-65.3%
2011Dec 30, 2011$12.59M–

More Pure Bioscience figures

See a number that looks wrong?